ResearcherUniversity of Wisconsin–MadisonActive in the last 2 years
Yu Chen
Matched on ORCID iD 0000-0002-9095-6609; OpenAlex author ID A5100402079. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2020: 2 papers · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper
Papers 5
- Programmable immunoprobiotics orchestrate antitumor immune response with Pin1 inhibition for pancreatic cancer treatment. Co-author DOI 10.1073/pnas.2507711122↗
- Nanodrug-bacteria conjugates-mediated oncogenic collagen depletion enhances immune checkpoint blockade therapy against pancreatic cancer. Co-author DOI 10.1016/j.medj.2024.02.012↗
- Synthetically Lethal Biomimetic Nutri-hijacker Hitchhikes and Reprograms KRAS Mutation-Driven Metabolic Addictions for Pancreatic Ductal Adenocarcinoma Treatme… First author DOI 10.1021/acsnano.3c04069↗
- Sequential delivery of nanoformulated α-mangostin and triptolide overcomes permeation obstacles and improves therapeutic effects in pancreatic cancer. Co-author DOI 10.1016/j.biomaterials.2020.119907↗
- Tailored Chemodynamic Nanomedicine Improves Pancreatic Cancer Treatment via Controllable Damaging Neoplastic Cells and Reprogramming Tumor Microenvironment. Co-author DOI 10.1021/acs.nanolett.0c02622↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Quanyin Hu · 2 shared papers, 2024–2025 · strength 0.47
- Paper Programmable immunoprobiotics orchestrate antitumor immune response with Pin1 inhibition for pancreatic cancer treatmen… DOI 10.1073/pnas.2507711122↗
- Paper Nanodrug-bacteria conjugates-mediated oncogenic collagen depletion enhances immune checkpoint blockade therapy against … DOI 10.1016/j.medj.2024.02.012↗
- Yukun Huang · 3 shared papers, 2020–2023 · strength 0.34
- Paper Synthetically Lethal Biomimetic Nutri-hijacker Hitchhikes and Reprograms KRAS Mutation-Driven Metabolic Addictions for … DOI 10.1021/acsnano.3c04069↗
- Paper Sequential delivery of nanoformulated α-mangostin and triptolide overcomes permeation obstacles and improves therapeuti… DOI 10.1016/j.biomaterials.2020.119907↗
- Paper Tailored Chemodynamic Nanomedicine Improves Pancreatic Cancer Treatment via Controllable Damaging Neoplastic Cells and … DOI 10.1021/acs.nanolett.0c02622↗
- Jun Chen · 3 shared papers, 2020–2023 · strength 0.34
- Paper Synthetically Lethal Biomimetic Nutri-hijacker Hitchhikes and Reprograms KRAS Mutation-Driven Metabolic Addictions for … DOI 10.1021/acsnano.3c04069↗
- Paper Sequential delivery of nanoformulated α-mangostin and triptolide overcomes permeation obstacles and improves therapeuti… DOI 10.1016/j.biomaterials.2020.119907↗
- Paper Tailored Chemodynamic Nanomedicine Improves Pancreatic Cancer Treatment via Controllable Damaging Neoplastic Cells and … DOI 10.1021/acs.nanolett.0c02622↗
- Sichen Yuan · 1 shared paper, 2025 · strength 0.27
- Sean M. Ronnekleiv‐Kelly · 1 shared paper, 2024 · strength 0.20
- Patrick Beard Schwartz · 1 shared paper, 2024 · strength 0.20
- Zhaoting Li · 1 shared paper, 2024 · strength 0.20
- Kai Guo · 1 shared paper, 2024 · strength 0.20
- Shuai Ren · 1 shared paper, 2024 · strength 0.20
- Chen Liang · 1 shared paper, 2020 · strength 0.10
- Jingxian Feng · 1 shared paper, 2020 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.